期刊文献+

谷氨酰胺、EPA、支链氨基酸对食管癌同步放化疗及胃癌术后辅助化疗患者的影响 被引量:24

Impact of glutamine, eicosapntemacnioc acid, branched-chain amino acid supplements on nutritional status and treatment compliance of esophageal cancer patients on concurrent chemoradiotherapy and gastric cancer patients on chemotherapy
原文传递
导出
摘要 目的 观察补充谷氨酰胺、二十碳五烯酸(EPA)、支链氨基酸对食管癌同步放化疗及胃癌术后辅助化疗患者的作用.方法 2013年4月至2014年4月因食管癌、胃癌在中国医学科学院肿瘤医院和北京桓兴病区拟行化疗或同步化放疗患者104例入组,数字随机分为试验组和对照组进行营养干预,两组均进行膳食指导及常规营养支持,试验组给予补充谷氨酰胺(20 g/d)、EPA (3.3 g/d)、支链氨基酸(8 g/d),对照组不进行补充.食管癌放化疗结束、胃癌3周期化疗结束时,比较治疗前后两组患者体成分分析结果、部分血液学指标、并发症发生率、治疗完成率.结果 试验组非脂组织及骨骼肌重量均显著增加,而对照组显著降低(P<0.05);试验组血白蛋白、红细胞、白细胞、血小板保持稳定(P>0.05),而对照组均显著下降;感染相关并发症发生率,试验组显著低于对照组(6%与19%,P<0.05);此外,试验组按治疗计划完成率显著高于对照组(96%与83%,P<0.05).结论 对于食管癌同步放化疗及胃癌术后辅助化疗患者,营养支持中补充谷氨酰胺、EPA、支链氨基酸有利于维持患者的营养状况、降低并发症发生率、提高患者的治疗顺应性. Objective To explore the effects of glutamine,eicosapntemacnioc acid (EPA) and branched-chain amino acids supplements in esophageal cancer patients on concurrent chemoradiotherapy and gastric cancer patients on chemotherapy.Methods From April 2013 to April 2014,a total of 104 esophageal and gastric carcinoma patients on chemotherapy or concurrent chemoradiotherapy were recruited and randomly divided into experimental and control groups.Both groups received dietary counseling and routine nutritional supports while only experimental group received supplements of glutamine (20 g/d),EPA (3.3 g/d) and branched-chain amino acids (8 g/d).And body compositions,blood indicators,incidence of complications and completion rates of therapy were compared between two groups.Results After treatment,free fat mass and muscle weight increased significantly in experiment group while decreased in control group (P < 0.05).And albumin,red blood cell count,white blood cell count and blood platelet count remained stable in experiment group while declined significantly in control group.During treatment,compared to control group,the incidences of infection-associated complication were lower (6% vs 19%,P < 0.05) and the completion rates of therapy were significantly higher in experiment group (96% vs 83%,P < 0.05).Conclusion Supplements of glutamine,EPA and branched-chain amino acids can help maintain nutrition status,decrease the complications and improve compliance for esophageal cancer patients on concurrent chemo-radiotherapy and gastric cancer patients on postoperative adjuvant chemotherapy.
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第10期766-769,共4页 National Medical Journal of China
关键词 胃肿瘤 化疗 放射治疗 预后 并发症 Gastrointestinal neoplasms Chemotherapy Radiotherapy Prognosis Complications
  • 相关文献

参考文献16

  • 1于康,周晓容,郭亚芳.恶性肿瘤住院患者营养风险和营养不足发生率及营养支持应用状况调查[J].肿瘤学杂志,2011,17(6):408-411. 被引量:153
  • 2Pan H, Cai S, Ji J, et al. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals [ J]. Nutr Cancer, 2013,65( 1 ) :62-70.
  • 3Argiles JM, Moore-Carrasco R, Fuster G, et al. Cancer cachexia : the molecular mechanisms[ J]. Int J Biochem Cell Biol, 2003,35 (4) :405-409.
  • 4Skipworth R J, Stewart GD, Dejong CH, et al. Pathophysiology of cancer eachexia: much more than host-tumour interaction? [ J]. Clin Nutr, 2007,26(6) :667-676.
  • 5Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer[ J]. Curr Opin Clin Nutr Metab Care, 2005,8 (3) :265-269.
  • 6Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition [ J]. Clin Nutr, 2008,27 (7) :793-799.
  • 7Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" [ J ]. Clin Nutr, 2010,29 (2) : 154-159.
  • 8Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus [ J ]. Lancet Oncol, 2011,12 ( 5 ) :489-495.
  • 9Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia [ J ]. Nat Rev Clin Oncol, 2013,10(2) :90-99.
  • 10Gaurav K, Goel RK, Shukla M, et al. Glutamine: A novel approach to chemotherapy-induced toxicity [ J ]. Indian J Med Paediatr Oncol, 2012,33 ( 1 ) : 13-20.

二级参考文献22

  • 1季加孚,武爱文.进展期胃癌新辅助化疗的研究进展[J].中华胃肠外科杂志,2007,10(4):394-395. 被引量:58
  • 2Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002 [J]. Clinical Nutrition, 2003, 22(4): 415-421.
  • 3Jie B, Jiang ZM, Nolan MT, et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a muhicenter,prospective cohort study in Baltimore and Beijing teaching hospitals [J]. Nutrition, 2010, 26 (11- 12): 1088-1093.
  • 4Schwegler I, yon Holzen A, Gutzwiller JP, et al. Nutri- tional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer [J]. Br J Surg, 2010, 97(1): 92-97.
  • 5Kondrup J, Rasmussen HH, Hamberg O, et al. Nutri- tional Risk Screening (NRS 2002): a new method based on an analysis of controlled clinical trials [J]. Clinical Nutri- tion, 2003, 22(3):321-336.
  • 6American Gastroenterological Association (AGA). Ameri- can Gastroenterological Association medical position state- ment: parenteral nutrition [J]. Gastroenterology, 2001,121 (4):966-969.
  • 7Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status [J]. JPEN, 1987, 11(1):8-13.
  • 8Guigoz Y, Vellas B J, Garry PJ. Mini Nutritional Assessment: a practical assessment tool for grading the nutritional state of elderly patients [J]. Facts and Research in Gerontonology, 1994, 4 (Suppl 2): 15-59.
  • 9Stratton R J, King CL, Stroud MA, et al. Malnutrition Univer- salScreening Tool predicts mortality and length of hospital stay in acutely ill elderly[J]. BrJ Nutr, 2006, 95(2~325-330.
  • 10Fu X L,Int J Radiat Oncol Biol Phys,1997年,39卷,3期,545页

共引文献188

同被引文献272

引证文献24

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部